MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Evaluation of pain in Parkinson’s disease

    B. Durmus, O. Yilmaz Kusbeci, I. Inci (Izmir, Turkey)

    Objective: To determine the prevalence of pain, types and characteristics of pain and the effect of pain on depression and daily living activities in early…
  • 2018 International Congress

    Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease

    A. Gera, G. Pal (Chicago, IL, USA)

    Objective: To illustrate an example of an improvement in chronic pain, following bilateral subthalamic nuclei (STN) deep brain stimulation (DBS) surgery in a Parkinson’s disease…
  • 2018 International Congress

    Subjective and objective urinary dysfunction in parkinson’s disease and atypical parkinsonisms

    Y. Lee, J. Kim (Seoul, Republic of Korea)

    Objective: To assess the relationship between subjective and objective urinary dysfunction in patients with Parkinson's disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy…
  • 2018 International Congress

    Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?

    A. Sarwar, S. Moore (Houston, TX, USA)

    Objective: To determine if REM sleep behavior disorder (RBD) is associated with excessive daytime sleepiness (ES) in military veterans with Parkinson’s disease (PD). Background: Nearly…
  • 2018 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD) before…
  • 2018 International Congress

    Relationship between dysphagia severity and gait disturbance in Parkinson’s disease

    C. Kobylecki, I. Shiderova, E. Michou (Salford, United Kingdom)

    Objective: Evaluate the relationship between falls, freezing of gait and swallowing disturbance in Parkinson’s disease (PD). Background: Dysphagia is a common non-motor symptom of PD…
  • 2018 International Congress

    Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

    A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

    Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…
  • 2018 International Congress

    Comparison of Treatment Effectiveness of Conventional Functional Training (CFT) to Occupational Therapy (OT) Multi-modal CASH Program (CASH) in Improving Non-motor Symptoms and Carer Stress of Parkinson’s (PD) Patient at Intermediate and Advanced State

    T. Tang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong)

    Objective: This study is a prospective pilot study to investigate the effectiveness of OT 'CASH' group therapy on intermediate and advanced PD patients in managing…
  • 2018 International Congress

    Mind and Movement in Parkinson’s disease: An experience with yoga

    S. Varanese, N. Modugno (Pozzilli, Italy)

    Objective: To evaluate the effects of a specially designed yoga program on mobilty, gait and quality of life in patients with PD. Background: The use…
  • 2018 International Congress

    Non-motor symptoms in Parkinson’s Disease: Frequency, types and correlated factors compared to a group of healthy controls. Results from the COPPADIS Study Cohort

    L. Planellas, M. Martí, P. Santacruz, A. Cámara, S. Jesus Maestre, F. Carrillo García, P. Mir, M. Aguilar, P. Pastor, J. García Caldentey, E. Estelrich Peyret, N. Caballol Pons, I. Legarda, B. Vives Pastor, J. Hernández Vara, G. Martí Andrés, I. Cabo, L. López Manzanares, M. Gallego-de-la-Sacristana, P. Martínez Martín, D. Santos García, G. COPPADIS STUDY (Barcelona, Spain)

    Objective: The aim of this study is to describe the prevalence and burden of NMS in a group of PD patients without dementia compared to…
  • « Previous Page
  • 1
  • …
  • 1166
  • 1167
  • 1168
  • 1169
  • 1170
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley